APA (7th ed.) Citation

S, Y., X, Z., RP, G., X, D., CY, C., JY, W., . . . Q, J. (2023). Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. American journal of hematology, 98(7), E183. https://doi.org/10.1002/ajh.26943

Chicago Style (17th ed.) Citation

S, Yang, et al. "Imatinib Compared with Second-generation Tyrosine Kinase-inhibitors in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase." American Journal of Hematology 98, no. 7 (2023): E183. https://doi.org/10.1002/ajh.26943.

MLA (9th ed.) Citation

S, Yang, et al. "Imatinib Compared with Second-generation Tyrosine Kinase-inhibitors in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase." American Journal of Hematology, vol. 98, no. 7, 2023, p. E183, https://doi.org/10.1002/ajh.26943.